Experience

Davis Polk is advising CSX Corp. on its acquisition of New England’s Pan Am Railways, Inc., whose rail carrier subsidiaries comprise North America’s largest regional railroad. Financial…

We are advising Sycamore Partners on its acquisition

Davis Polk is advising IHS Markit on its all-stock merger with S&P Global that values IHS Markit at an enterprise value of $44 billion. Under the terms of the merger agreement, each…

Davis Polk advised the sales agent on the SEC-registered at-the-market offering by Revance Therapeutics, Inc. of its common stock for up to an aggregate amount of $125 million. Based…

Davis Polk advised the representatives of the several underwriters in connection with the $352 million follow-on offering of 11,000,000 shares of common stock of Jamf Holding Corp. sold by…

Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with a $307 million public offering of 4,150,000 shares of common stock…

Davis Polk advised Signify Health on its acquisition of PatientBlox. The acquisition accelerates Signify’s prospective provider payment capabilities for episodes of care, supporting the…

Davis Polk advised the sales agents in connection with an SEC-registered at-the-market offering by BioNTech SE of its ordinary shares represented by American depositary shares for up to an…

Davis Polk advised the representative of the initial purchasers in connection with a Rule 144A/Regulation S offering by Finance of America Funding LLC of $350 million aggregate…

Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A/Regulation S offering by MPH Acquisition Holdings LLC, a wholly owned subsidiary of MultiPlan…